O'Hara, Jr.
Garald P. O'Hara, Jr., North Canton, OH US
Patent application number | Description | Published |
---|---|---|
20090161350 | COOL ENVIRONMENT LAMP WITH ANTI-FOG COMPONENT - A lamp that can be used in a refrigerated or cold environment where an overall light output measured on a target plane is not significantly reduced due to condensation or fog includes a housing including a translucent cover, an LED disposed in the housing, and an anti-fog film. The LED is disposed in the housing with relation to the translucent cover such that light from the LED passes through the cover. The anti-fog film is disposed on at least one of the surfaces of the translucent cover. | 06-25-2009 |
Gerald P. O'Hara, Jr., Valley View, OH US
Patent application number | Description | Published |
---|---|---|
20090280695 | BI-PIN CONNECTOR AND A LAMP EMPLOYING THE SAME - A bi-pin connector for a luminaire includes a base and pins that can rotate relative to the base. The pins can also translate relative to a light fixture housing in a direction transverse to the axis about which the pins rotate. A luminaire including the bi-pin connector is also disclosed. | 11-12-2009 |
Richard O'Hara, Jr., Ouincy, MA US
Patent application number | Description | Published |
---|---|---|
20090263351 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases - Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-γ or TNF-α. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease. | 10-22-2009 |
Richard O'Hara, Jr., Quincy, MA US
Patent application number | Description | Published |
---|---|---|
20120020916 | USE OF IL-12 AND IL-12 ANTAGONISTS IN THE TREATMENT OF AUTOIMMUNE DISEASES - Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-γ or TNF-α. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease. | 01-26-2012 |
20130089515 | Use of IL-12 and IL-12 Antagonists in the Treatment of Autoimmune Diseases - Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-γ or TNF-α. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease. | 04-11-2013 |